Hampe Irene A I, Friedman Justin, Edgerton Mira, Morschhäuser Joachim
Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Department of Oral Biology, University at Buffalo, Buffalo, New York, United States of America.
PLoS Pathog. 2017 Sep 27;13(9):e1006655. doi: 10.1371/journal.ppat.1006655. eCollection 2017 Sep.
The opportunistic fungal pathogen Candida albicans frequently produces genetically altered variants to adapt to environmental changes and new host niches in the course of its life-long association with the human host. Gain-of-function mutations in zinc cluster transcription factors, which result in the constitutive upregulation of their target genes, are a common cause of acquired resistance to the widely used antifungal drug fluconazole, especially during long-term therapy of oropharyngeal candidiasis. In this study, we investigated if C. albicans also can develop resistance to the antimicrobial peptide histatin 5, which is secreted in the saliva of humans to protect the oral mucosa from pathogenic microbes. As histatin 5 has been shown to be transported out of C. albicans cells by the Flu1 efflux pump, we screened a library of C. albicans strains that contain artificially activated forms of all zinc cluster transcription factors of this fungus for increased FLU1 expression. We found that a hyperactive Mrr1, which confers fluconazole resistance by upregulating the multidrug efflux pump MDR1 and other genes, also causes FLU1 overexpression. Similarly to the artificially activated Mrr1, naturally occurring gain-of-function mutations in this transcription factor also caused FLU1 upregulation and increased histatin 5 resistance. Surprisingly, however, Mrr1-mediated histatin 5 resistance was mainly caused by the upregulation of MDR1 instead of FLU1, revealing a previously unrecognized function of the Mdr1 efflux pump. Fluconazole-resistant clinical C. albicans isolates with different Mrr1 gain-of-function mutations were less efficiently killed by histatin 5, and this phenotype was reverted when MRR1 was deleted. Therefore, antimycotic therapy can promote the evolution of strains that, as a consequence of drug resistance mutations, simultaneously have acquired increased resistance against an innate host defense mechanism and are thereby better adapted to certain host niches.
机会性真菌病原体白色念珠菌在其与人类宿主的终生关联过程中,经常产生基因改变的变体以适应环境变化和新的宿主生态位。锌簇转录因子的功能获得性突变导致其靶基因的组成性上调,是获得性耐药的常见原因,尤其是在口服念珠菌病的长期治疗期间,该突变导致对广泛使用的抗真菌药物氟康唑产生耐药性。在本研究中,我们调查了白色念珠菌是否也会对抗菌肽组蛋白5产生抗性,组蛋白5在人类唾液中分泌,以保护口腔黏膜免受病原微生物侵害。由于组蛋白5已被证明可通过Flu1外排泵转运出白色念珠菌细胞,我们筛选了一个白色念珠菌菌株库,这些菌株包含该真菌所有锌簇转录因子的人工激活形式,以寻找增加的FLU1表达。我们发现,通过上调多药外排泵MDR1和其他基因赋予氟康唑抗性的高活性Mrr1,也会导致FLU1过表达。与人工激活的Mrr1类似,该转录因子中自然发生的功能获得性突变也会导致FLU1上调并增加对组蛋白5的抗性。然而,令人惊讶的是,Mrr1介导的对组蛋白5的抗性主要是由MDR1的上调而非FLU1引起的,这揭示了Mdr1外排泵以前未被认识的功能。具有不同Mrr1功能获得性突变的耐氟康唑临床白色念珠菌分离株被组蛋白5杀死的效率较低,当MRR1被缺失时,这种表型得以恢复。因此,抗真菌治疗可以促进菌株的进化,由于耐药性突变,这些菌株同时获得了对先天宿主防御机制的增强抗性,从而更好地适应某些宿主生态位。